Adhera Therapeutics Analysis

ATRXDelisted Stock  USD 0.72  0.00  0.00%   
Adhera Therapeutics is overvalued with Real Value of 0.61 and Hype Value of 0.72. The main objective of Adhera Therapeutics pink sheet analysis is to determine its intrinsic value, which is an estimate of what Adhera Therapeutics is worth, separate from its market price. There are two main types of Adhera Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Adhera Therapeutics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Adhera Pink Sheet Analysis Notes

About 22.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.52. Adhera Therapeutics last dividend was issued on the 3rd of August 2017. The entity had 1:20 split on the 6th of October 2022. Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana. Adhera Therapeutics is traded on OTC Exchange in the United States.The quote for Adhera Therapeutics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Adhera Therapeutics please contact BS BS at 919 518 3748 or go to https://adherathera.com.

Adhera Therapeutics Investment Alerts

Adhera Therapeutics is not yet fully synchronised with the market data
Adhera Therapeutics has some characteristics of a very speculative penny stock
Adhera Therapeutics has a very high chance of going through financial distress in the upcoming years
Adhera Therapeutics currently holds 7.35 M in liabilities with Debt to Equity (D/E) ratio of 56.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Adhera Therapeutics has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Adhera Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Adhera Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Adhera Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Adhera to invest in growth at high rates of return. When we think about Adhera Therapeutics' use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (6.35 M) with loss before overhead, payroll, taxes, and interest of (157 K).
Adhera Therapeutics currently holds about 849 K in cash with (665 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 22.0% of Adhera Therapeutics shares are held by company insiders

Adhera Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.18 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Adhera Therapeutics's market, we take the total number of its shares issued and multiply it by Adhera Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Adhera Therapeutics Outstanding Bonds

Adhera Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Adhera Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Adhera bonds can be classified according to their maturity, which is the date when Adhera Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Adhera Therapeutics Predictive Daily Indicators

Adhera Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Adhera Therapeutics pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Adhera Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Adhera Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Adhera shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Adhera Therapeutics. By using and applying Adhera Pink Sheet analysis, traders can create a robust methodology for identifying Adhera entry and exit points for their positions.
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana. Adhera Therapeutics is traded on OTC Exchange in the United States.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Adhera Therapeutics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Top Crypto Exchanges Now

   

Top Crypto Exchanges

Search and analyze digital assets across top global cryptocurrency exchanges
All  Next Launch Module
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Adhera Pink Sheet

If you are still planning to invest in Adhera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adhera Therapeutics' history and understand the potential risks before investing.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Global Correlations
Find global opportunities by holding instruments from different markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments